Skip to main content
. Author manuscript; available in PMC: 2016 Aug 15.
Published in final edited form as: Cancer. 2015 Apr 29;121(16):2840–2848. doi: 10.1002/cncr.29430

Table 1.

Patients characteristics

Variable All (n=330) Intensive
(n=197)
Non-intensive
(n=133)
P-Value

Age (SD) 69.9 (6.8) 66.3 (4.6) 75.2 (6.2) < 0.0001

Male gender (%) 195 (59.1%) 110 (55.8%) 85 (63.9%) 0.14

White Race (%) 321 (97.3%) 190 (96.4%) 131 (98.5%) 0.47

Marital Status (%) 0.05
Single 36 (10.9%) 22 (11.2%) 14 (10.5%)
Married 243 (73.6%) 147 (74.6%) 96 (72.2%)
Divorced 26 (7.9%) 19 (9.6%) 7 (5.3%)
Widow 25 (7.6%) 9 (4.6%) 16 (12.0%)

Education (%) 0.04
High school or less 136 (41.2%) 75 (38.1%) 61 (45.9%)
College 150 (45.5%) 86 (43.7%) 64 (48.1%)
Post-Grad 44 (13.3%) 36 (18.3%) 8 (6.0%)

Therapy-related disease? (%) 48 (14.6%) 29 (14.7%) 19 (14.3%) 0.91

Comorbidity Index (SD) 1.9 (1.8) 1.7 (1.6) 2.2 (2.1) 0.02

Disease Risk (%) 0.40
Favorable 25 (7.6%) 18 (9.1%) 7 (5.3%)
Intermediate 165 (50.0%) 99 (50.3%) 66 (49.6%)
High Risk 140 (42.4%) 80 (24.2%) 60 (45.1%)

ECOG performance status (SD) 0.88 (0.56) 0.77 (0.55) 1.0 (0.55) < 0.0001

Achieved complete remission 171 (51.8%) 140 (71.1%) 31 (23.3%) < 0.0001

Received allogeneic HCT 109 (33.0%) 102 (51.8%) 7 (5.3%) < 0.0001

Median survival in days [95%CI] 340 [280–391] 390 [309–487] 255 [198–354] < 0.0001

SD = Standard deviation; ECOG = Eastern Cooperative Oncology Group; HCT = Hematopoietic Stem Cell Transplantation.